Autolus Therapeutics plc (AUTL) has a market capitalization of $399.21M and trades at $1.50. The 52-week range is 1.105-2.7.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -1.4, Earnings Per Share (EPS) of $-1.08, annual revenue of $75.56M.
The stock has a beta of 1.94, operates in the Healthcare sector.
